AI in medicine, explained for everyoneGeneral information only, not medical advice · Our standards
How Far

Regulation · Regulation

UK accepts all 44 recommendations on regulating medical AI

Policy watch
How it was checked
AI-assisted source check. Not clinically reviewed. ()
Last updated
Next review
Page ID
TR-018

Our editorial standards · 4 references · Corrections

Policy watch

This is policy news, not a product, so it has no evidence rating and no country track, and it isn't counted in the tracker total.

Next milestone: MHRA draft guidance on managing changes to AI-enabled devices by December 2026; full implementation roadmap by Spring 2027. GOV.UK

General information only, not medical advice. Talk to your doctor about your situation. Read the disclaimer.

On 6 October 2026 the UK Government accepted all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, and the MHRA opened Phase 3 of its AI Airlock sandbox for monitoring AI devices in use. Most changes are still plans: draft guidance is due by December 2026 and a roadmap by spring 2027.

How far away is this?

Policy watch

'Announced only': these are accepted recommendations and plans. Apart from the Airlock sandbox opening, nothing from this response is in force yet, and 'accepted' doesn't mean 'implemented'. Many items only commit to exploring options.

Where is it approved?

RegionRegulatorStatusNotes
United KingdomMHRANot applicablePolicy, not a product. All 44 recommendations accepted on 6 Oct 2026; draft guidance due Dec 2026; roadmap due spring 2027.[1]
United StatesFDANot applicablePolicy, not a product. UK only.
European UnionCE mark / EMANot applicablePolicy, not a product. UK only.
AustraliaTGANot applicablePolicy, not a product. UK only.

A UK policy decision, not a product approval, so no region has a product status. "Register not searched yet" means we haven't searched that regulator's register; it doesn't mean the product is or isn't available. Approval in one country isn't approval in another.

What is it?

This is a policy decision, not a product. It sets out how UK rules for AI medical devices should change, moving from a one-off approval to monitoring a device throughout its working life.

What's the evidence?

  1. The Government accepted all 44 recommendations of the National Commission (report published 10 September 2026) and set out how it plans to deliver them with the devolved governments. Scotland's government said it will set out its own response in due course.[1]

    Evidence stage: Announced only · #c1

  2. The MHRA committed to draft guidance by December 2026 on managing changes to AI devices as they adapt over time, and to consult in 2027 on how AI devices are qualified and classified.[1]

    Evidence stage: Announced only · #c2

  3. MHRA AI Airlock Phase 3 opened for applications on 6 October 2026, focused on monitoring AI devices once they're in use (post-market surveillance). To be considered for the first review wave, developers must apply before 31 October 2026. The application window then stays open year-round, until the MHRA closes the call, with a later shortlisting in spring 2027. This phase is funded until April 2029.[4]

    Evidence stage: Announced only · #c3

  4. Other commitments: explore staged authorisation pathways that could let promising AI tools be used in the NHS earlier, under close supervision, while more evidence is gathered; strengthen patient engagement; work on access to redress; and consider how to make clear when patients should be told AI is being used in their care. A full implementation roadmap is due by spring 2027.[2]

    Evidence stage: Announced only · #c4

  5. The response marks all 44 recommendations '(Accept)'. Many responses commit only to 'explore' or 'consider' options, and some rely on future secondary legislation.[2]

    Evidence stage: Announced only · #c5

  6. The Commission was set up by the MHRA in September 2025 as an independent, non-statutory advisory body and gathered evidence from more than 12,000 people.[1]

    Evidence stage: Announced only · #c6

What does it mean for me?

Nothing changes for UK patients straight away. Over time it could mean AI tools are monitored more closely after launch, clearer rules on when you're told AI is used in your care, and clearer routes to redress. Staged approval could also mean some AI tools reach the NHS earlier, under supervision, while evidence is still being gathered. It doesn't apply in Australia, the EU or the US.

What could I ask my doctor?

  • Is an AI tool being used in my care, and is it a regulated medical device?
  • Who do I complain to if an AI tool gets something wrong?

These are general starting points, not a recommendation to choose any particular test or treatment.

Change history

  • : First published.
  • : Review label corrected: this page was not clinically reviewed. Earlier labels saying 'independent fact-check' and 'clinical review' were wrong; checks so far were AI-assisted source checks only.

General information only, not medical advice. Talk to your doctor about your situation. AI-assisted source check. Not clinically reviewed.

References

  1. GOV.UK / MHRA press release, 6 Oct 2026. gov.uk (2026). Official. https://www.gov.uk/government/news/government-backs-recommendations-of-nhs-doctors-led-ai-commission
  2. Government response to the National Commission. gov.uk. Official. https://www.gov.uk/government/publications/government-response-to-the-national-commissions-recommendations-on-the-regulation-of-ai-in-healthcare
  3. National Commission recommendations report. gov.uk. Official. https://www.gov.uk/government/publications/national-commission-into-the-regulation-of-ai-in-healthcare-recommendations-for-a-future-regulatory-framework
  4. AI Airlock Phase 3 application. gov.uk. Regulator. https://www.gov.uk/government/publications/ai-airlock-phase-3-application

Publisher shown as the website hosting each source. Dates are given where the source label includes them.